---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-134948"
form_type: "8-K"
ticker: "CBUS"
cik: "0001705843"
company_name: "Cibus, Inc."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-20T00:00:52.335651+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cibus streamlines focus on Rice weed traits, targets $30M annual cash burn by 2026

## Summary
- Focusing on HT1 and HT3 herbicide tolerance traits in Rice for commercial launch in Latin America (2027-2028) and U.S. mid-south (2028).
- Plans cost reductions to reduce annual net cash burn to ~$30M by 2026, including rationalizing headcount and non-core facilities.
- Regulatory wins: California approval for gene-edited Rice field research (Feb 2025); USDA-APHIS designated two Canola traits as not regulated (Apr 2025).
- Ecuador determined HT1/HT3 Rice traits equivalent to conventional breeding (Apr 2025), important as country prohibits GMO planting.
- Partner-funded sustainable ingredients program targeting nominal revenues in 2025 with commercial expansion in 2026.

## SEC filing metadata
- accession: 0001193125-25-134948
- form_type: 8-K
- ticker: CBUS
- cik: 0001705843
- company_name: Cibus, Inc.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1705843/000119312525134948/0001193125-25-134948-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1705843/000119312525134948/d931877d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-134948
- JSON: https://secwatch.observer/filing/0001193125-25-134948.json
- Plain text: https://secwatch.observer/filing/0001193125-25-134948.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
